Dry Powder Inhalers (DPI)

The LUND University Sweden, Emmercon and the Swedish Foundation for Strategic Research proudly present the following study: The Match Between...

Kiel University, Germany, and  Meggle GmbH & Co. KG present "A functional study of tubing material for the spray drying...

Dry powder inhalation therapy has been effective in treating localized lung diseases such asthma, chronic obstructive pulmonary diseases (COPD), cystic...

Despite advances in targeted therapies and immunotherapy in lung cancer, chemotherapy remains the backbone of treatment in most patients at...

Nintedanib is a drug approved to treat idiopathic pulmonary fibrosis (IPF) and all chronic progressive fibrosing interstitial lung diseases. Delivery...

The surface drying process is an important technology in the pharmaceutical, biomedical, and food industries. The final stage of formulation...

The pharmaceutical industry has two main ways to generate new products. The first option is to look for new drug...

Soluplus is a polymer that has been explored to prepare nanocomposites for pulmonary drug delivery and is non-toxic. However, its...

Judgment of the General Court in Joined Cases T-279/20, T-288/20 and T-283/20 | CWS Powder Coatings and Others v Commission...

Dry powder inhalers (DPIs) are regularly used to treat respiratory diseases. Adding extrinsic fine excipient particles to the blend of...